Abstract Details

Title Therapeutic Target of Memory B Cells Depletion Helps to Tailor Administration Frequency of Rituximab in Neuromyelitis Optica Spectrum Disorders Patients

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 310

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Christine Lebrun Frenay, MD, FAAN (CRCSEP Neurologie) PRESENTER	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Mikael Cohen (Hopital Pasteur)	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��